Literature DB >> 6810941

Human high density lipoprotein (HDL3) binding to rat liver plasma membranes.

G K Chacko.   

Abstract

The binding of human 125I-labeled HDL3 to purified rat liver plasma membranes was studied. 125I-labeled HDL3 bound to the membranes with a dissociation constant of 10.5 micrograms protein/ml and a maximum binding of 3.45 micrograms protein/mg membrane protein. The 125I-labeled HDL3-binding activity was primarily associated with the plasma membrane fraction of the rat liver membranes. The amount of 125I-labeled HDL3 bound to the membranes was dependent on the temperature of incubation. The binding of 125I-labeled HDL3 to the rat liver plasma membranes was competitively inhibited by unlabeled human HDL3, rat HDL, HDL from nephrotic rats enriched in apolipoprotein A-I and phosphatidylcholine complexes of human apolipoprotein A-I, but not by human or rat LDL, free human apolipoprotein A-I or phosphatidylcholine vesicles. Human 125I-labeled apolipoprotein A-I complexed with egg phosphatidylcholine bound to rat liver plasma membranes with high affinity and saturability, and the binding constants were similar to those of human 125I-labeled HDL3. The 125I-labeled HDL3-binding activity of the membranes was not sensitive to pronase or phospholipase A2; however, prior treatment of the membranes with phospholipase A2 followed by pronase digestion resulted in loss of the binding activity. Heating the membranes at 100 degrees C for 30 min also resulted in an almost complete loss of the 125I-labeled HDL3-binding activity.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6810941     DOI: 10.1016/0005-2760(82)90094-7

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

1.  HDL3-mediated cholesterol efflux from cultured enterocytes: the role of apoproteins A-I and A-II.

Authors:  G Herold; U Hesse; F Wisst; C Fahr; M Fahr; G Rogler; I Geerling; E F Stange
Journal:  Lipids       Date:  1994-11       Impact factor: 1.880

2.  Cholesterol feeding to rats does not modulate the expression of binding sites for HDL on liver membranes.

Authors:  F M Maggi; A L Catapano
Journal:  Experientia       Date:  1986-10-15

3.  Lipid utilization by human lymphocytes is correlated with high-density-lipoprotein binding site activity.

Authors:  Q Xu; G Jürgens; L A Huber; G Böck; H Wolf; G Wick
Journal:  Biochem J       Date:  1992-07-01       Impact factor: 3.857

4.  Effect of essential fatty acid deficiency on lipid composition of basolateral plasma membrane of pig intestinal mucosal cells.

Authors:  V Duranthon; L Frémont; C L Léger
Journal:  Lipids       Date:  1991-03       Impact factor: 1.880

5.  Monoclonal antibodies to human apolipoprotein AI: probing the putative receptor binding domain of apolipoprotein AI.

Authors:  C M Allan; N H Fidge; J R Morrison; J Kanellos
Journal:  Biochem J       Date:  1993-03-01       Impact factor: 3.857

6.  Interaction in vivo and in vitro of apolipoprotein E-free high-density lipoprotein with parenchymal, endothelial and Kupffer cells from rat liver.

Authors:  D Schouten; M Kleinherenbrink-Stins; A Brouwer; D L Knook; T J Van Berkel
Journal:  Biochem J       Date:  1988-12-01       Impact factor: 3.857

7.  Affinity purification of the hepatic high-density lipoprotein receptor identifies two acidic glycoproteins and enables further characterization of their binding properties.

Authors:  H Hidaka; N H Fidge
Journal:  Biochem J       Date:  1992-05-15       Impact factor: 3.857

8.  Uptake of apolipoprotein E-rich and apolipoprotein E-poor subfractions of high-density lipoprotein by liver membranes and HepG2 cells.

Authors:  Y D Fragoso; E R Skinner
Journal:  Biochem J       Date:  1995-10-15       Impact factor: 3.857

9.  A recombinant apoA-1--protein A hybrid reproduces the binding parameters of HDL to its receptor.

Authors:  L Monaco; H M Bond; K E Howell; R Cortese
Journal:  EMBO J       Date:  1987-11       Impact factor: 11.598

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.